# SI-BONE To Present at BofA Securities 2026 Healthcare Conference on May 12, 2026
Canonical URL: https://biopharmsignal.com/news/SIBN/si-bone-to-present-at-bofa-securities-2026-healthcare-conference-on-may-12-2026
Ticker: SIBN
Company: Si-Bone
Source: Si-Bone
Published: 2026-04-30 20:09 EST
Original Source URL: https://investor.si-bone.com
## Summary

SANTA CLARA, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today announced that the company will be participating in the upcoming 2026 BofA Securities

## Article Body
SANTA CLARA, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today announced that the company will be participating in the upcoming 2026 BofA Securities
## Recent Company News
- 2026-05-11 20:09 EST — [SI-BONE, Inc. Reports Financial Results for the First Quarter 2026 and Raises 2026 Guidance](https://biopharmsignal.com/news/SIBN/si-bone-inc-reports-financial-results-for-the-first-quarter-2026-and-raises-2026-guidance) — Source: Si-Bone
- 2026-04-30 20:09 EST — [SI-BONE To Present at BofA Securities 2026 Healthcare Conference on May 12, 2026](https://biopharmsignal.com/news/SIBN/si-bone-to-present-at-bofa-securities-2026-healthcare-conference-on-may-12-2026) — Source: Si-Bone
- 2026-04-20 20:09 EST — [SI-BONE To Report First-Quarter 2026 Financial Results on May 11, 2026](https://biopharmsignal.com/news/SIBN/si-bone-to-report-first-quarter-2026-financial-results-on-may-11-2026) — Source: Si-Bone
- 2026-02-23 21:09 EST — [SI-BONE, Inc. Reports Record Financial Results for the Fourth Quarter 2025 and Issues 2026 Guidance](https://biopharmsignal.com/news/SIBN/si-bone-inc-reports-record-financial-results-for-the-fourth-quarter-2025-and-issues-2026-guidance) — Source: Si-Bone
- 2026-02-17 21:30 EST — [SI-BONE To Present at TD Cowen 46th Annual Health Care Conference on March 2, 2026](https://biopharmsignal.com/news/SIBN/si-bone-to-present-at-td-cowen-46th-annual-health-care-conference-on-march-2-2026) — Source: Si-Bone
## Related News
- 2026-07-21 12:05 EST — VRCA — [Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel](https://biopharmsignal.com/news/VRCA/verrica-pharmaceuticals-and-medomie-pharma-enter-into-exclusive-distribution-mar-abf61522)
- 2026-07-21 11:30 EST — ABEO — [Cincinnati Children's Activated as the Seventh Qualified Treatment Center for ZEVASKYN®](https://biopharmsignal.com/news/ABEO/cincinnati-children-s-activated-as-the-seventh-qualified-treatment-center-for-ze-8382d043)
- 2026-07-21 10:28 EST — GSK — [ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults alongside INSTI-powered long-acting injectable innovation at AIDS 2026](https://biopharmsignal.com/news/GSK/viiv-healthcare-to-present-phase-iiib-data-comparing-dovato-with-biktarvy-in-tre-1ff3f640)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)